SCHEMBL4661585

SCHEMBL4661585

C=C1CCC(NC(=O)OCCCC)(C(=O)O)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.37
NPC1 O15118 7/20 0.37
HPGD P15428 6/20 0.37
SMN1; SMN2 Q16637 6/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
EPHX1 P07099 1/20 0.36
LMNA P02545 1/20 0.35
ACHE P22303 6/20 0.35
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
CASP1 P29466 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
MCL1 Q07820 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4661779 0.85 RAB9A (0.37) RAB9ANPC1HPGDSMN1; SMN2CYP1A2
SCHEMBL2722735 0.84 EPHX1 (0.44) RAB9AHPGDEPHX1LMNAACHE
SCHEMBL19640034 0.82 EPHX1 (0.42) RAB9ANPC1HPGDSMN1; SMN2EPHX1
SCHEMBL1536750 0.82 KMT2A (0.42) RAB9ANPC1HPGDSMN1; SMN2EPHX1
SCHEMBL4053495 0.80 KMT2A (0.41) RAB9ANPC1SMN1; SMN2EPHX1ACHE
SCHEMBL526390 0.80 KMT2A (0.41) RAB9ANPC1SMN1; SMN2EPHX1ACHE
SCHEMBL28742071 0.77 CXCR5 (0.53) RAB9ANPC1HPGDSMN1; SMN2CYP1A2
SCHEMBL27536155 0.74 LMNA (0.45) RAB9ANPC1HPGDSMN1; SMN2CYP1A2
SCHEMBL27533695 0.73 CXCR5 (0.49) RAB9ANPC1HPGDSMN1; SMN2CYP1A2
SCHEMBL27569650 0.73 CXCR5 (0.42) RAB9ANPC1HPGDSMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007787-A2 HCV INHIBITORS COMPRISING BETA AMINO ACIDS AND THEIR USES Novartis AG (CH) 2008-12-31 EP disclosed
WO-2007121124-A2 HCV INHIBITORS COMPRISING BETA AMINO ACIDS AND THEIR USES NOVARTIS AG (CH) 2007-10-25 WO disclosed